Santen Pharmaceutical Azioni (OTC: SNPHF)

Ultime notizie per Santen Pharmaceutical (OTC:SNPHF) Azioni

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

SANTEN PHARM CO by Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has announced the disposal of 93,391 treasury shares at ...

Santen Pharma Announces Stock-Linked Remuneration Plan

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has completed a share buyback program, repurchasing 3,06...

Santen Pharmaceutical Concludes Share Buyback

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co. has reinforced its corporate governance system to bolster corp...

Santen Pharmaceutical Enhances Governance for Shareholder Value

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has successfully completed the disposal of 93,391 treasu...

Santen Pharmaceutical Completes Share Disposal

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co. is committed to enhancing its corporate governance to improve ...

Santen Pharmaceutical Advances Governance and Diversity

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has announced the repurchase of 2,855,300 of its common ...

Santen Pharmaceutical Reports Share Buyback Progress

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has completed a buyback of 2,857,200 common shares for a...

Santen Pharmaceutical Advances Share Buyback Program

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has resolved to dispose of 30,715 treasury shares on Sep...

Santen Pharmaceutical Rewards Leadership with Stock Plan

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has successfully completed the disposal of 30,715 treasu...

Santen Pharma Completes Key Stock Remuneration Plan

Santen Pharmaceutical Co (JP:4536) has released an update. Santen Pharmaceutical Co., Ltd. has announced the buyback of 1,348,400 of its common sha...

Comments

Santen Pharmaceutical

Notizie

Ultime notizie per Santen Pharmaceutical (OTC:SNPHF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO